396 related articles for article (PubMed ID: 23496921)
21. [Thoughts of the combination of medicine and engineering and collaborative innovation on surgery in China].
Lyu ZJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jun; 23(6):562-565. PubMed ID: 32521975
[TBL] [Abstract][Full Text] [Related]
22. Mergers and innovation in the pharmaceutical industry.
Comanor WS; Scherer FM
J Health Econ; 2013 Jan; 32(1):106-13. PubMed ID: 23220457
[TBL] [Abstract][Full Text] [Related]
23. How academia and the pharmaceutical industry can work together: the president's lecture, annual meeting of the American Thoracic Society, San Francisco, California.
Rosenblatt M
Ann Am Thorac Soc; 2013 Feb; 10(1):31-8. PubMed ID: 23509330
[TBL] [Abstract][Full Text] [Related]
24. The innovation value chain of patents: Breakthrough in the patent commercialization trap in Chinese universities.
Gong H; Nie L; Peng Y; Peng S; Liu Y
PLoS One; 2020; 15(3):e0230805. PubMed ID: 32214371
[TBL] [Abstract][Full Text] [Related]
25. Value of pharmaceuticals: ensuring the future of research and development.
Serajuddin HK; Serajuddin AT
J Am Pharm Assoc (2003); 2006; 46(4):511-6. PubMed ID: 16913396
[TBL] [Abstract][Full Text] [Related]
26. National Heart, Lung, and Blood Institute and the translation of cardiovascular discoveries into therapeutic approaches.
Galis ZS; Black JB; Skarlatos SI
Circ Res; 2013 Apr; 112(9):1212-8. PubMed ID: 23620235
[TBL] [Abstract][Full Text] [Related]
27. Health research and innovation: Can we optimize the interface between startups/pharmaceutical companies and academic health care institutions or not?
Dhainaut JF; Blin O; Herry F; ; Benito S; Bilbault P; Cauterman M; Favrel-Feuillade F; Fazi-Leblanc S; Germain C; Goehrs C; Grosskopf C; Labarthe B; Lechat P; Malciu C; Marquet P; Miceli-Richard C; Peyret O; Rattenbach R; de Saint-Exupéry E
Therapie; 2020; 75(1):113-123. PubMed ID: 31948660
[TBL] [Abstract][Full Text] [Related]
28. Guidelines, editors, pharma and the biological paradigm shift.
Singh AR; Singh SA
Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
[TBL] [Abstract][Full Text] [Related]
29. Lost opportunities.
Phan P; Wong D
Nature; 2017 Dec; 552(7683):S18. PubMed ID: 29220004
[No Abstract] [Full Text] [Related]
30. Developing a new model for the invention and translation of neurotechnologies in academic neurosurgery.
Leuthardt EC
Neurosurgery; 2013 Jan; 72 Suppl 1():182-92. PubMed ID: 23254807
[TBL] [Abstract][Full Text] [Related]
31. Translational research and the evolving landscape for biomedical innovation.
Kaitin KI
J Investig Med; 2012 Oct; 60(7):995-8. PubMed ID: 22918200
[TBL] [Abstract][Full Text] [Related]
32. How should we support pharmaceutical innovation?
Grootendorst P
Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
[TBL] [Abstract][Full Text] [Related]
33. A lesson from Japan: research and development efficiency is a key element of pharmaceutical industry consolidation process.
Shimura H; Masuda S; Kimura H
Drug Discov Ther; 2014 Feb; 8(1):57-63. PubMed ID: 24647159
[TBL] [Abstract][Full Text] [Related]
34. Knowledge translation in tri-sectoral collaborations: An exploration of perceptions of academia, industry and healthcare collaborations in innovation adoption.
Ii SS; Fitzgerald L; Morys-Carter MM; Davie NL; Barker R
Health Policy; 2018 Feb; 122(2):175-183. PubMed ID: 29191387
[TBL] [Abstract][Full Text] [Related]
35. Obstacles and opportunities in Chinese pharmaceutical innovation.
Ni J; Zhao J; Ung CO; Hu Y; Hu H; Wang Y
Global Health; 2017 Mar; 13(1):21. PubMed ID: 28340579
[TBL] [Abstract][Full Text] [Related]
36. Open-access public-private partnerships to enable drug discovery--new approaches.
Müller S; Weigelt J
IDrugs; 2010 Mar; 13(3):175-80. PubMed ID: 20191434
[TBL] [Abstract][Full Text] [Related]
37. Safeguarding innovation through an economic downturn.
Barker R
Expert Rev Pharmacoecon Outcomes Res; 2010 Aug; 10(4):347-9. PubMed ID: 20715908
[No Abstract] [Full Text] [Related]
38. From HTS to Phase I: the Institute for Therapeutics Discovery and Development at the University of Minnesota.
Dosa PI; Georg GI; Gurvich VJ; Hawkinson JE; Walters MA; Wong HL
Comb Chem High Throughput Screen; 2014 Mar; 17(3):231-40. PubMed ID: 24409956
[TBL] [Abstract][Full Text] [Related]
39. Crowdsourcing biomedical research: leveraging communities as innovation engines.
Saez-Rodriguez J; Costello JC; Friend SH; Kellen MR; Mangravite L; Meyer P; Norman T; Stolovitzky G
Nat Rev Genet; 2016 Jul; 17(8):470-86. PubMed ID: 27418159
[TBL] [Abstract][Full Text] [Related]
40. [Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness].
Hedner T; Gatenbeck L
Lakartidningen; 2012 Jun 27-Jul 17; 109(26-28):1280-1. PubMed ID: 22852257
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
